CiPA talks from Sophion symposium at SPS in Prague

At this years' SPS in Prague Sophion hosted a symposium titled: The CiPA initiative - how it can change the way we do drug development in the future.

We had the pleasure of having the below three speakers and you can see their talks here: The CiPA initiative - how it will change the way we do drug development in the future.

• Bernard Fermini, co-chair of the Comprehensive In Vitro Proarrhythmia Assay (CiPA) Ion Channel Working Group, member of the CiPA Steering Committee.
  CiPA: The four letter word that may revolutionize in vitro cardiac safety testing

• Simon Hebeisen, BSYS
  Evolving market needs in safety screening: beyond hERG and CiPA
  
• Marc Rogers, Metrion Bioscience
  Using high quality HTS automated patch clamp data from human cardiac ion channels and in silico action potential modelling to cost–effectively predict QT prolongation and arrhythmia risk for CiPA